Michael Seo

Dr. Michael Seo is chief technology officer at Fermat. Michael joined Fermat in 2005 and has over 20 years of experience in commercially applied mathematical modelling. Michael brings to the firm a background in software development, signal processing, and image recognition and classification algorithms. Prior to joining his brothers at Fermat, he was director of software and algorithm development for a cellular analysis company (Amnis Corporation, Seattle). Before Amnis Michael was part of the pattern recognition team whose algorithms were core to the first FDA-approved, fully-automated cancer screening device (NeoPath/TriPath, Redmond, Washington). Michael received a Ph.D. in electrical engineering from the University of Texas at Austin (1993) and B.S. degrees in electrical engineering, computer science and mathematics (triple major) from Southern Methodist University (1986).